|
Socio-demographical features
| |
|
Sex-ratio (M:F)
|
2.75
|
|
Median age, yr (IQRa)
|
53.7 (43–64)
|
|
Low socio-economical standardb
n (%)
|
5 (16.7)
|
|
Living in Abidjan n (%)
|
18 (60.0)
|
|
Ethnical origin
| |
|
Akan-speaking areas n (%)
|
11 (36.6)
|
|
Gur-speaking areas n (%)
|
5 16.6)
|
|
Kru-speaking areas n (%)
|
4 (13.3)
|
|
Mandé-speaking areas n (%)
|
7 (23.3)
|
|
Foreign born (Burkina Faso) n (%)
|
3 (10.0)
|
|
Lifestyle features
| |
|
History of heavy drinking n (%)
|
7 (23.3)
|
|
Tobacco use n (%)
|
3 (10.0)
|
|
Cassava consumption n (%)
|
19 (63.3)
|
|
Maize flour consumption n (%)
|
16 (53.3)
|
|
Peanut consumption n (%)
|
20 (66.7)
|
|
Risk factors of infection
| |
|
Dental treatment n (%)
|
8 (26.6)
|
|
Invasive medical practicesc n (%)
|
11 (36.6)
|
|
Ritual scarifications n (%)
|
12 (40.0)
|
|
Sex-transmitted infections n (%)
|
3 (10.0)
|
|
Clinical features
| |
|
Metabolic disease (Type 2 diabetes, obesity) n (%)
|
6 (20.0)
|
|
Hepatomegaly n (%)
|
25 (83.3)
|
|
Jaundice n (%)
|
21 (70.0)
|
|
Bruises n (%)
|
7 (23.3)
|
|
Portal anastomoses n (%)
|
5 (16.6)
|
|
Liver pain n (%)
|
20 (66.7)
|
|
Ascites n (%)
|
21 (70.0)
|
|
Multi-nodular tumors n (%)
|
27 (90.0)
|
|
ECOG clinical stage**** n (%)
| |
|
- 1 or 2
|
8 (26.7)
|
|
- 3 or 4
|
22 (73.3)
|
|
Biochemistry
| |
|
Alpha-feotoprotein >400 ng/mL n (%)
|
13 (43.3)
|
|
Hemoglobin (g/dL ± SD)
|
10.2 ± 2.0
|
|
Prothrombin ratio (% ± SD)
|
69.3 ± 20.5
|
|
ASAT (UI/mL, mean ± SEM)
|
211 ± 45
|
|
ALAT (UI/mL, mean ± SEM)
|
143 ± 26
|
